'CANDOPRIMAVAC' INACTIVATED LIQUID VACCINE AGAINST CANDIDIASIS, METHOD FOR PRODUCTION THEREOF AND METHOD OF TREATMENT AND PROPHYLAXIS USING SAME

摘要

The group of inventions relates to medical microbiology and the pharmaceutical industry, and more particularly to vaccine preparations and to methods for the production and use thereof, and can be used for the treatment and prophylaxis of localised and systemic Candida-associated lesions. Moreover, the vaccine comprises no less than 14 strains of 3 species of Candida fungi, namely: Candida albicans - 7, Candida krusei - 4, Candida glabrata - 3 of different locations, isolated from various fungal lesions on the skin, mucosa and internal organs, inter alia, Candida fungi strains with various degrees of resistance to antifungal drugs, and which are deposited at the Depository of the Institute of Microbiology and Virology of the National Academy of Sciences of Ukraine.